CPH
EW icon

C Partners Holding’s Edwards Lifesciences EW Stock Holding History

C Partners Holding’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,457
Closed -$143K – 86
2018
Q3 		$143K Sell
2,457
-2,661
-52% -$130K 0.05% 31
2018
Q2 		$248K Sell
5,118
-162
-3% -$7.56K 0.09% 50
2018
Q1 		$246K Sell
5,280
-2,424
-31% -$105K 0.1% 29
2017
Q4 		$289K Buy
+7,704
New +$283K 0.12% 68

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

C Partners Holding's EW Position: Q4 2018 in Review

C Partners Holding sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 2,457 shares — an estimated $143K sold.

C Partners Holding first reported a position in EW in Q4 2017 and held it in 4 quarters. The position peaked at $289K in Q4 2017. 874 funds tracked by Wall St. Rank hold EW as of Q4 2018.

  • C Partners Holding reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 2,457 Edwards Lifesciences shares in Q4 2018, an estimated $143K.
  • C Partners Holding first reported a position in Edwards Lifesciences in Q4 2017 and held it in 4 quarters.
  • C Partners Holding's Edwards Lifesciences position peaked at $289K in Q4 2017.
  • 874 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.